Tower Research Capital LLC (Trc) Axogen, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Axogen, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 861 shares of AXGN stock, worth $20,362. This represents 0.0% of its overall portfolio holdings.
Number of Shares
861
Previous 5,079
83.05%
Holding current value
$20,362
Previous $55,000
72.73%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding AXGN
# of Institutions
186Shares Held
41.6MCall Options Held
86.4KPut Options Held
14.3K-
First Light Asset Management, LLC Edina, MN5.81MShares$137 Million12.43% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$76.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.68MShares$63.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.43MShares$57.5 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO1.96MShares$46.3 Million0.75% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $1B
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...